Intracervical Vasopressin

Part of paid clinical trials in Greenville, South Carolina.

Sponsor
Prisma Health-Upstate
Study ID
NCT07102615
Phase
PHASE4
Status
Recruiting

Conditions

  • Retained Products of Conception

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 51 Years
Healthy Volunteers
Not accepted

Interventions

  • Intracervical injection of Vasopressin — DRUG
    Intracervical injection of Vasopressin
  • Intracervical Injection of saline — DRUG
    Intracervical Injection of saline

Study Details

This randomized study looks at whether using a medicine injected into the cervix of the uterus (intracervical), called vasopressin, helps to achieve better removal of retained products of conception (RPOC). RPOC means that after a pregnancy has ended (through miscarriage, abortion, or delivery), some parts of the pregnancy tissue, usually from the placenta or fetus, have stayed in the uterus. A hysteroscopic removal of RPOC is one type of treatment. This is a surgical procedure where a doctor uses a small camera attached to a thin tube (called a hysteroscope) to look inside the uterus. The main goal of the study is : • To add to the existing research through this study to see if the injection of intracervical vasopressin leads to improved completion rates of hysteroscopic management of RPOC. Participants will: • would be randomized to receive either vasopressin intracervical injection or a placebo injection (non-active saline) during your procedure. Information from the procedure will be collected from the participant's medical record.

Key Dates

Start date
Oct 30, 2025
Status verified
Oct 2025
Primary completion
Aug 1, 2026
Completion
Dec 1, 2026

Study Design

Enrollment
50 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Treatment
    Vasopressin- 20 mL of a dilute solution (5 units of Vasopressin in 20cc injectable saline)
  • Placebo Comparator: Placebo
    20 mL of saline

Primary Outcome Measure

Completion of procedure hysteroscopically [ Time Frame: from start of procedure to end of procedure ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The OB/GYN CenterGreenvilleSouth Carolina29605
Erica Lowing, MD
864-455-1600

Find similar trials in Greenville, SC